Cargando…
A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
Cystic fibrosis (CF) is a potentially fatal genetic disease that causes serious lung damage. With time, researchers have a more complete understanding of the molecular-biological defects that underlie CF. This knowledge is leading to alternative approaches regarding the treatment of this condition....
Autores principales: | Zaher, Anas, ElSaygh, Jude, Elsori, Dalal, ElSaygh, Hassan, Sanni, Abdulsabar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266292/ https://www.ncbi.nlm.nih.gov/pubmed/34268058 http://dx.doi.org/10.7759/cureus.16144 |
Ejemplares similares
-
A Review of Clinical Trials That Contributed to Chronic Obstructive Pulmonary Disease Treatment Protocols
por: ElSaygh, Jude, et al.
Publicado: (2021) -
Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities
por: ElSaygh, Jude, et al.
Publicado: (2023) -
A Literature Review of Major Clinical Trials That Contributed to Treatment Protocols of Irritable Bowel Syndrome With Diarrhea
por: Elsaygh, Hassan, et al.
Publicado: (2022) -
The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability
por: Meng, Xin, et al.
Publicado: (2016) -
Novel reaction to new cystic fibrosis medication Trikafta
por: Stashower, Julian, et al.
Publicado: (2021)